Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to supply chain and domestic manufacturing capacity.

White House OfficeCenters For Disease Control & Prevention (CDC)Executive Office of the President (EOP)Food & Drug Administration (FDA)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATE

Medicare/Medicaid

View all

Issues related to drug pricing and implementation of the Inflation Reduction Act.
H.R. 946/S. 1862, ORPHAN Cures Act.
H.R. 1492, the Ensuring Pathways to Innovative Cures Act.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to drug pricing and pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.

Centers For Medicare and Medicaid Services (CMS)Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATEWhite House Office

Taxation/Internal Revenue Code

View all

H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.

HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATEWhite House Office

Trade (domestic/foreign)

View all

Issues related to tariffs.

SENATEExecutive Office of the President (EOP)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)White House Office

Lobbyists (4)

GREG D'ANGELO

RACHEL JONES HENSLER

BRETT BAKER

MARY BETH SAVARY TAYLOR